chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Neck, back, shoulder entire arm and chest pain all on the other side of body from shot.
Patient suffered a tiny brain bleed and subdural hematoma and fell from our boat to the pier on the afternoon of April 17.  I drove him to the ER for evaluation where a CT scan revealed the brain bleed.  He was subsequently transported to the emergency unit that evening.  He was disoriented and suffered a concussion as well.  He had daily blood work and was treated with Levetiracetam for 5 days post discharge on 4/22.
Case number PHEH2013US021111 is an initial spontaneous report received from a health care professional on 08 OCT 2013. This report refers to a 12-year-old patient of unknown gender who was inadvertently vaccinated with FLUCELVAX (batch number: unknown) intramuscularly on 07 OCT 2013. No adverse event was reported following this administration error.
Woke up that Sunday a.m. feeling very tired.  Complained of arms feeling heavy and a headache.  Later that day complained of numbness and tingling which progressed bilaterally up both her arms throughout that day and into the next several days.  Complained of being cold.  She slept up to 16 hours/day.  Contacted the physician on-call on Monday (Labor Day) who suggested that we wait a week to see what course the symptoms took.  Symptoms continued and progressed to complaints of difficulty walking due to heaviness of legs.  Numbness and tingling progressed above elbows, but no further.  No difficulty breathing.  On Wednesday we went to see her primary care physician who felt she had mono, and that it was not related to the HPV vaccine.  (patient had NO sore throat)  Her doctor ran blood tests, but these returned negative for mono. Patient began to get less tired and less weak beginning on Friday, September 5th, during the day, but then returned to the weakened state on Saturday through Tuesday.  And then rapidly recovered to her usual self by Saturday, September 13th.  She has had no recurrence of the symptoms since.  (NOTE:  Her maternal grandfather was diagnosed with Myasthenia Gravis at age 70, and a cousin on her mother's side has Juvenile Rheumatoid Arthritis that first surfaced after a tetanus vaccine when she was 10 years old).
Information has been received from a pharmacist referring to 2 newborns. Background: Since June 2015, there had been 1645 times (30 minutes each time= 822.5 hours) that the temperature dropped below 36F. Of course, there was 144 times (30 minutes each time=72 hours) that temperature was below 32F, the lowest being 29.7F. On 04-JUL-2015, there was a low temperature of 30.2F. On 07-JUL-2015 the patients were vaccinated with the improperly stored RECOMBIVAX HB strength 2.5/0.5 (units not provided) (lot number K020216 and expiration date of 17-SEP-2016) (dose and route of administration were not reported). There was no product quality complaint (PQC). This is one of several reports received from the same reporter. Additional information has been requested.
Rec.'d shot at 11:40 a.m. Noticed adverse event at 1:00 p.m. c/o burning and itching of the face. Stated that she felt her face swelling. 3:00 p.m. Reported to the school nurse. c/o itching and facial burning. Minimum amount of redness noted. temp - 98.4 / pulse -72 & regular. No difficulty breathing. 4:05 p.m. To ER with a family member.
Had IM Flu & TDAP vaccine (L) deltoid. Chills/rigors started at 8pm 10/15/10 with temp > 101.1 intermittently next 20 hrs. Arthralgia (bilateral hips & ankles), nausea & weakness, TMJ sore, chest tightness/pressure, edema face. Pale sunburn darker face reported. Labs. Missed work saw PMD, symptom management.
Two days after vaccination (Sunday), a sudden, moderate pain occurred in both of my legs. This pain continued until the Monday evening, where the pain became severe and it was difficult to walk or even stand up. Throughout the next few days, occasional pain/soreness/stiffness occurred in both legs of varying intensity. On Tuesday or Wednesday night, a red rash began to form on both legs. The rash spread throughout both legs. The rash was diagnosed as palpable purpura on Sunday 12/5, 9 days after vaccination. The doctor suspected the purpura occured due to Henoch-Schönlein Purpura (HSP).
Information has been received from a pharmacist concerning a male who was accidentally vaccinated with a small amount of mumps virus vaccine live instead of receiving an intradermal sensitivity test. Subsequently, the pt experienced slight redness at the site. Addtl info has been requested.
The report was first received from a practice manager on 07-SEP-2018, and it was recognized as non-valid because report did not obtain any patient identify. Follow-up information has been received from the practice manager on 18-SEP-2018. This spontaneous report refers to a patient of unknown age and gender. Information of concurrent condition, medical history and concomitant therapy was not provided. On 27-AUG-2018, the patient was vaccinated with an improperly stored dose of PROQUAD (recombinant Human albumin) (strength and route were unknown) (lot# R006216 and expiration date 28-AUG-2019) for prophylaxis. The sterile diluent (MERCK) was properly stored. No adverse event was reported. The excursion temperature on 22-SEP-2017, 17-OCT-2017, 06-DEC-2017, 07-DEC-2017, 30-JAN-2018, 23-FEB-2018, 18-MAY-2018, 05-JUL-2018, 15-AUG-2018 was 6 degree Celsius for maximize 8.75 hours. The excursion temperature on 02-MAR-2018, 27-AUG-2018 was 7 degree Celsius for maximize 8.75 hours. The excursion temperature on 07-DEC-2017 was 8 degree Celsius for maximize 15 hours. The call was not because of data logger. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1809USA003709: US-009507513-1810USA001951: US-009507513-1810USA001952: US-009507513-1810USA001953: US-009507513-1810USA001954: US-009507513-1810USA001955: US-009507513-1810USA001956: US-009507513-1810USA001957: US-009507513-1810USA001959.
About 80% of dose drained down the arm of patient when Rph injected due to unsecured leur lock; bleeding at the injection site; syringe issue; A spontaneous report was received from a consumer concerning about a 73 years old female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced medication error of syringe connection issue (Incorrect dose administered and syringe issue) and event of vaccination site bleeding (vaccination site hemorrhage).  The patient's medical history was not reported. Concomitant medications were not reported.  On 26 Mar 2021, prior to the onset of the events the patient received their second planned doses of mRNA-1273 (Batch number: 028A21A) via intramuscular for the prophylaxis of COVID-19 infection.  On 26 Mar 2021, the reporter reported that during vaccination the leur-lock was not secured to the syringe and when it administered to the patient, he pushed the plunger in, and he felt that liquid running out down the arm. When he went to secure the needle, needle stayed in patient's arm. So about 80% of dose ran down the arm. The patient also experienced bleeding at the site of the injection.  Laboratory details was not mentioned. Treatment information was not provided.  Action taken with mRNA-1273 in response to the event are unknown.  The outcome of the event device connection issue remain resolved.  On 26 Mar 2021, the outcome of the event medication error of syringe connection issue was considered resolved. The outcome of the event bleeding at the site of injection was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, vaccination site hemorrhage, a causal relationship cannot be excluded. This report also refers to a case of  Incorrect dose administered and syringe issue, for mRNA-1273, lot #: 028A21A.
pt exp headache off & on, started about 10am tylenol taken, nausea later in day, headache worse in afternoon. md office visit after 4pm. vomiting, headache, tingling in fingers.
After Hepatitis B # 1, this patient had vomiting and diarrhea 1 week after the injection, and it lasted 1 - 2 days. Hepatitis B # 1 done on 04/05/01. Hepatitis B # 2, had on 05/05/01, the patient had vomiting, dizziness, was light headed, rash on the left arm, and a bruise on the right leg and left arm. Her sickness started 11 - 12 hours after the injection.
painful mass at injection site; swelling at injection site, swelling is extending outwards; chills; body aches; painful mass at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (painful mass at injection site), VACCINATION SITE SWELLING (swelling at injection site, swelling is extending outwards), CHILLS (chills), MYALGIA (body aches) and VACCINATION SITE PAIN (painful mass at injection site) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. FJ8757 and 065F21A) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Nov-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Dec-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Dec-2021, the patient experienced VACCINATION SITE MASS (painful mass at injection site), VACCINATION SITE SWELLING (swelling at injection site, swelling is extending outwards), CHILLS (chills), MYALGIA (body aches) and VACCINATION SITE PAIN (painful mass at injection site). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) at a dose of 500 milligram twice a day. At the time of the report, VACCINATION SITE MASS (painful mass at injection site), VACCINATION SITE SWELLING (swelling at injection site, swelling is extending outwards), CHILLS (chills), MYALGIA (body aches) and VACCINATION SITE PAIN (painful mass at injection site) outcome was unknown.            Symptoms: It was reported that the patient had experienced adverse event post 48 hours of vaccination, and was seen on call with doctor. the swelling was extended outwards from mass, patient was going to visit her primary care doctor the next day if symptoms don't improve. Patient did not experienced any events after first dose of Moderna vaccine.  No concomitant medications were reported
Case previously recorded as MA2009-6265. Initial case report received from a health care professional on 25 NOV 2009. Twenty children younger than 04 years of age received FLUVIRIN intramuscular inadvertent administration on an unknown date. No adverse events reported. Medical history: Not reported. Agency reference no. NA09-008851.
Expired vaccine used; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 40-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Nov-2021 at 10:00 AM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 19-Nov-2021 at 10:00 AM,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 19-Nov-2021 at 10:00 AM, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant and treatment medications were reported. No information was reported. Patient race was reported as B. It was reported that vital signs taken and were normal.   This case was linked to MOD-2021-391981 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 23-Nov-2021: Follow up version: Follow up contains race of the patient. Additional reporter added.
Initial and follow up information has been received from a registered nurse and from the doctor's office concerning a 46 year old female patient who was allergic to dust, who on 06-FEB-2008 at 03:30 PM was vaccinated subcutaneous into left deltoid with a dose of pneumococcal 23v polysaccharide vaccine (lot # 658447/1132U). In follow up report it was reported that on 07-FEB-2008, a day after the injection was administered, the patient experienced achy, had flu like symptoms, her arm was sore at injection site and developed cellulitis. She saw her primary doctor and on 08-FEB-2008 was prescribed ZITHROMAX. On 11-FEB-2008, the patient's injection site reported as "OK." She recovered on an unknown day. This is one of 3 cases from the same source. Additional information is not expected.
Dull left sided chest pain began on 3/20/2018, occasionally radiated to the back, and was relieved with position change, primarily leaning forward. The pain continued and worsened on 3/23/2018 when the patient sought care at a local ED. The left sided chest pain became sharper and more severe and was not relieved with position changes any longer. The patient was admitted to the hospital for suspected peri- vs myocarditis secondary to smallpox vaccine. The patient was discharged on 3/28/2018 with a diagnosis of acute myocarditis and is scheduled to follow-up with outpatient cardiology for a repeat echocardiogram in 4 weeks.
Pt. received Influenza vaccine at 0915 on October 29, 14. She developed a rash on arms and chest around 1330. The rash did not itch, but stated skin felt like sandpaper. The pt ate dinner then began vomiting at 1930 until 2300. Pt had no fever. Rash is gone and pt is asymptomatic on October 30, 2014.
Localized redness at injection site approx 48 hrs after administration Follow up w/patient on 12/16 & she states redness is self resolving
had his two shots and just got shingles /suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.  Additional details were provided as follows: The reporter was the patient's wife. The age at vaccination was not reported. The reporter stated that, her husband had 2 shots and just got shingles. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization for shingles, time to onset for event and laboratory confirmation for shingles were not provided.
Mid April - about two weeks after second dose of vaccine, I noticed that nail had really ragged lines instead a smooth curve and there was a slight dark red discoloration about 3 -4 mm in width but right beneath of the curve of the white part of nail. After 2-3 weeks, nail was continuously was receding past where to where I normally cut my nails. It keeps receding on it's own - I haven't cut it that short but the white keeps increasing the part of the nail that connects with the skin keeps lowering and lowering. End of May, I went to see a dermatologist. They couldn't determine anything and said to come back if it gets worse. I went home. Condition continued in early June and then it started to worsen. When I'm at work and type, the nails would hurt. It feels like a needle poking under the front tip of the nail. Nail lifting from the nailbed. I went to Dr. instead of dermatologist. She had blood tests done. Blood tests came back normal. I told her vaccine timeline and she said it may be due to it - that may immune system is over-reacting. She gave me a six day treatment for a steroid. By day four of the steroid, the darker red had subsided a little and the pain had gone away. After I finished a treatment, it was another week or two - I still see a slight discoloration on the nail and when I type it doesn't hurt anymore. There is still a slight discoloration behind the nail and it isn't back to normal.
She received her first dose of Moderna on friday 4/16/21. She is complaining of pain underneath the left arm as of saturday 4/17/21. It is a little swollen to the eye. She is so much pain that she can not put on her bra. She told us on monday 4/19/21.
throwing up; having chills; This spontaneous case was reported by a consumer and describes the occurrence of VOMITING (throwing up) and CHILLS (having chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 13-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Feb-2021, the patient experienced VOMITING (throwing up) and CHILLS (having chills). At the time of the report, VOMITING (throwing up) and CHILLS (having chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No treatment and concomitant drugs are provided.   Reporter did not allow further contact
Splotchy, hive-like rash began about 6 hours, post vax. Parents report child has a "cough and temperature, fussy and rubbing at skin". Seen at ER with fever of 99F (rectal). No RX. Dx'd with allergic reaction.
was in waiting area and about 10 min after vaccine said she got tachycardiac and checked her heart rate on the apple watch and it was 140.  She felt tunnel vision also   did not alert staff in waiting area as did not want to call attention to herself.  Symptoms subsided after 1-2 minutes.  said she would have passed out if she stood up at the time.  Went back to work and told coworker.  Vaccine clinic staff called her this am and she is fine- no further symptoms.
She tested positive for Covid-19 a week later after receiving the first dose of the vaccine; She tested positive for Covid-19 a week later after receiving the first dose of the vaccine; This is a spontaneous report from a Pfizer-sponsored program IBCC (Inbound Call Center for HCPs) received from a contactable consumer (patient). A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot/batch number unknown), via an unspecified route of administration on 29Dec2020 at a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported.  The patient took the first dose of Covid-19 vaccine on 29Dec2020. She tested positive for Covid-19 a week later after receiving the first dose of the vaccine. She is scheduled to get the second dose on 19Jan2021 and she was asking what to do. The outcome of the event was unknown.  Information about lot/batch number has been requested.
Kidney pain; Dizziness; Headache; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of RENAL PAIN (Kidney pain), DIZZINESS (Dizziness), HEADACHE (Headache) and NAUSEA (Nausea) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032L20A and 027L20LA) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included LITHIUM for an unknown indication.   On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 28-Feb-2021, the patient experienced RENAL PAIN (Kidney pain), DIZZINESS (Dizziness), HEADACHE (Headache) and NAUSEA (Nausea). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, RENAL PAIN (Kidney pain), DIZZINESS (Dizziness), HEADACHE (Headache) and NAUSEA (Nausea) outcome was unknown.            Most recent FOLLOW-UP information incorporated above includes: On 28-Jun-2021: Follow-up information received updated reporter contact information and is considered non-significant.
Right arm has HURT & muscles have gone lame & cannot lift the arm up while laying down, have to grab it with the left hand to lift the right arm.  Has been lame for 4 months.  Even hurts at the top of the shoulder joint.  Muscle from shoulder to elbow aches & has no strength.  Even Acupuncture treatments did not make the muscles less lame.
Vaccine was administered 5/21/18. Patient started to feel achy and tired 6/1/18. 6/2/18 she developed erythematous popular vesicular lesions of face, neck, back, abdomen, arms, (L) leg, redness at injection site.
Severe arm pain in the first few days. Pain has continued from 1/14/2019 to present 3/12/2019 but intensity has decreased.
REDNESS SWELLING HEAT TO THE RIGHT DELTOID, STILL SPREADING. PT EXPERIENCED CHILLS, FATIGUE, PAIN SWELLING TO EXTREMITY AND NAUSEA.
This spontaneous report was received from a healthcare worker regarding a 19 year old female patient with no pertinent medical history reported. On an unknown date the patient was vaccinated with VAQTA (lot number and expiration date not reported) (dose and route not specified). The reporter stated that the patient received a pediatric dose of VAQTA. No adverse reaction reported. Additional information is not expected.
The day of vaccination the patient experienced shoulder pain that migrated to this arm and side. He reporeted having to take OTC pain medication every 6 hours for 2 days. His symptom had started to improve by 09/29/14. Symptom onset once patient was back at home.
Fatigue swollen lips mouth and tongue sore lips bleeding chest burning   No treatment  Lasted one week
Vaccine with expiration date of 09/30/22 was administered to patient on 10/9/2022.  Pt did not report any side effects/symptoms.
Patient presented for a 1st dose Moderna vaccine. Gave patient IMZ in IMZ room. As I was discussing and answering addtional questions and chatting with patients (about 5 minutes later), said he was starting to feel lightheaded and then immediately fell forward from the IMZ chair and passed out onto the floor, hitting his head pretty hard. He lost consiousness for about a minute and regained consiousness. Alerted my technician to call 911 due to the possibility of a concussion. Provided patient with an ice pack for his neck (offered drink and snack but EMS told us not to give any food/beverage until they arrived). Patient stay seated on the floor until EMS arrived. He said he felt fine and wife was very worried but he complained of headache, flushing/being hot, and neck pain. Patient wanted to sit instead of remain lying on the floor. EMS arrived - checked pulse, patient was fine - but they took him to local hospital to have his head and neck checked out. Symptoms before: said he was lightheaded. During: loss of consiousness, face turned red. After: headache, flushing, neck pain.
Symptoms achy, fever, "head is killing her". Tx: self administered: APAP. 9/24/10 symptoms occurred. Temp. of 100 degrees called back for temp.